Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Inclusion Criteria: * Patients with neutropenic fever who have existing malignancy or have undergone hematopoietic stem cell transplantation * Requires hospitalization for intravenous (IV) empiric antibiotic therapy Exclusion Criteria: * Fungal or viral infection requiring additional therapy * Known acute viral hepatitis * Known to be human immunodeficiency virus (HIV) positive * Expected requirement for hemodialysis while on study therapy * Received \>24 hours of systemic antibacterial therapy within 72 hours of initiation of inpatient IV study drug * Past or current history of epilepsy or seizure disorder * Evidence of immediately life-threatening disease, progressively fatal disease, or life expectancy of 3 months or less.